Poly (lactic-co-glycolic acid)(PLGA) is the most prevalent polymer drug delivery vehicle in
use today. There are about 20 commercialized drug products in which PLGA is used as an …

The development of biodegradable polymers represents a revolution in medicine spanning
over 50 years and leading to significant biotechnological advancements in drug delivery …

Over the past few decades, long acting injectable (LAI) depots of polylactide-co-glycolide
(PLGA) or polylactic acid (PLA) based microspheres have been developed for controlled …

The development of oral dosage forms for poorly water-soluble active pharmaceutical
ingredients (APIs) is a persistent challenge. A range of methods has been explored to …

Background Poly (glycolic acid), poly (lactic acid) and poly (lactic-co-glycolic acid) were
approved by the United States Food and Drug Administration (FDA) in the 1970s as …

Abstract Poly (d, l-lactic-co-glycolic acid)(PLGA) is the most frequently used biodegradable
polymer in the controlled release of encapsulated drugs. Understanding the release …

Over recent decades, poly (lactic-co-glycolic acid)(PLGA) based nano-and micro-drug
delivery vehicles have been rapidly developed since PLGA was approved by the Food and …

Injectable biodegradable and biocompatible copolymers of lactic and glycolic acid (PLGA)
are an important advanced delivery system for week-to-month controlled release of …

Nowadays, nano/micro-encapsulation as a pioneering technique may significantly improve
the bioavailability and durability of Natural bioactives. For this purpose, chitosan as a …

In this study, we describe composite scaffolds composed of synthetic and natural materials
with physicochemical properties suitable for tissue engineering applications. Fibrous …